William Humphries - Director, Clearside Biomedical, Inc

As of January 11, 2022


William Humphries Net Worth

  • Net worth is estimated to be at least $7.37M
  • Owns at least 5,586 units of Clearside Biomedical, Inc stock

William Humphries Trading

  • Largest purchase of shares was 5,586 units , worth over $9.94K on August 18, 2020
  • In total has made about 8 transactions over 5 years
  • Usually trades in June, with the busiest year in 2020 and 2017
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

William Humphries Mailing Address

  • Mailing address is C/o Strata Skin Sciences, Inc. 5 Walnut Grove Drive Suite 140 Horsham PA 19044 PA

Clearside Biomedical, Inc Executive Compensation

Name
Year
Salary
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
George Lasezkay 2020 $503,313 $286,513 $402,827 $163,577 $14,777 $1,371,007
George Lasezkay 2019 $371,235 $181,772 $299,915 $159,809 $32,461 $1,045,192
Charles A. Deignan 2020 $342,876 $59,250 $152,010 $78,004 $9,450 $641,590
Charles A. Deignan 2019 $332,890 $105,264 $107,753 $106,000 $9,300 $661,207
Thomas Ciulla 2020 $367,375 $59,250 $152,010 $83,578 $9,450 $671,663
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1539029/000119312521135345/d59948ddef14a.htm

Clearside Biomedical, Inc Insider Trading

  • The most recent transaction was 8,833 units sold on January 20, 2022 by Charles Deignan worth over $18.46K
  • In the last 6 years, insiders at Clearside Biomedical, Inc sold an estimated value of $11.89M and bought an estimated value of $13.78M
  • The most active traders are Clay Thorp, Director,  Charles Deignan, Chief Financial Officer,  and George Lasezkay, CEO
  • Insider trading is most common in June, with the busiest year in 2017

Clearside Biomedical, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1